Dividing prostate cancer cells seen through scanning electron micrograph
Media playback is unsupported on your device

Prostate cancer drug ruling a 'fiasco', says charity

A charity says a decision by the NHS in England to reject a drug for men with prostate cancer is a "fiasco".

Abiraterone is already given to patients at the end-of-life after chemotherapy as it gives patients an extra few months.

But the National Institute for Health and Care Excellence said it was not cost-effective to be offered before.

BBC health correspondent Dominic Hughes reports.

  • 15 Aug 2014
  • From the section Health
Go to next video: Hopes for prostate cancer vaccine